Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2018 | 10-2017 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 44 | 40 |
| Accounts receivable | -630 | 115 |
| Accounts payable and accrued liabilities | 723 | 575 |
| Other Working Capital | 792 | 498 |
| Other Operating Activity | -2,263 | -2,460 |
| Operating Cash Flow | $-1,333 | $-1,232 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -15 | -21 |
| Purchase Sale Intangibles | -273 | -1,200 |
| Other Investing Activity | 386 | 195 |
| Investing Cash Flow | $63 | $-1,060 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | -130 | N/A |
| Debt Issued | 1,484 | 2,083 |
| Other Financing Activity | -71 | 0 |
| Financing Cash Flow | $1,283 | $2,083 |
| Exchange Rate Effect | -4 | 6 |
| Beginning Cash Position | 3 | 206 |
| End Cash Position | 11 | 3 |
| Net Cash Flow | $13 | $-209 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,333 | -1,232 |
| Capital Expenditure | -323 | -1,255 |
| Free Cash Flow | -1,657 | -2,487 |